https://www.selleckchem.com/products/BEZ235.html
6%) had a negative MRSA nasal swab with a subsequent cultured documented MRSA infection during their admission. Identified infections were bacteremia (n = 2) and confirmed pneumonia (n = 1). MRSA nasal swab had a sensitivity of 62% (95% CI, 0.24-0.91), specificity of 98% (95% CI, 0.96-0.99), positive predictive value of 38% (95% CI, 0.21-0.6), and NPV of 99% (95% CI, 0.98-1). A negative MRSA nasal swab has a 99% NPV for subsequent MRSA infections in AML patients with no prior history of MRSA colonization or infection. Based on these find
Like
Comment
Share
